It is also the psychiatric illness that holds the record for having the highest mortality rate. The UCSD research explores ...

Revive Therapeutics (TSE:RVV) has released an update. Revive Therapeutics has announced promising research showcasing psilocybin’s ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...

In an exploration of psychedelic medicine's potential for treating one of psychiatry's most challenging conditions, ...

"Our findings suggest that psilocybin may be helpful in supporting meaningful psychological change in a subset of people with ...

REL-P11 is a proprietary, low-dose, modified-release psilocybin formulationSingle-Ascending Dosing (SAD) study to evaluate safety and ...

However, not everyone with depression will be eligible for this innovative treatment. The study, led by researchers from ...

If the Colorado Springs City Council approves the zoning measure, it would essentially bar the centers from operating in ...

In a groundbreaking exploration of psychedelic medicine's potential for treating one of psychiatry's most challenging ...

A former firefighter tried psilocybin in his backyard, and got amazing relief. Slowly, medical research is starting to ...